European Medicines Agency Supporting Coronavirus Treatment Development
The European Medicines Agency (EMA) stated it was initiating measures to hurry up the development of vaccines and coverings to combat the novel coronavirus that has taken the lives of 427 people as of early Tuesday.
WHO has declared the flu-like coronavirus a global crisis, and experts say a lot is still unknown, together with its mortality rate and transmission ways.
“EMA can support medicine developers with all available regulatory instruments to advance and facilitate the event of effective steps to fight and stop the spread of coronavirus,” the company stated.
It stated it was looking for potential antivirals or vaccines to treat or forestall the virus epidemic and that it was analyzing all available information on makers’ drug pipelines.
British drug-making company GlaxoSmithKline (GSK) has stated it was working with the Coalition for Epidemic Preparedness Innovations (CEPI) in an attempt to make a vaccine.
“EMA has activated its plan for managing emerging health dangers,” EMA Executive Director Guido Rasi stated, adding that the company would provide fast-track scientific advice and provides prompt suggestions on any proposed medication developments.